Rannou, F., Desallais, L., Nguyen, C., Daste, C., Kirren, Q., Lefevre-Colau, M., Launay, O., Mouhsine, H., Ruiz, B., Moreau, G., Langenfeld, F., Dolimier, E., Do, H., Azoulai, R., Berenbaum, F., Boissier, M., Salles, J., Zagury, J. (2025). Safety and immunogenicity of PPV-06, an active anti-IL-6 immunotherapy targeting low-grade inflammation against knee osteoarthritis: a randomized, double-blind, placebo-controlled, clinical phase 1 study. Nature Communications. https://doi.org/10.1038/s41467-025-64710-6